On ECHEMI
Home > Drugs > diabetes
diabetes
Diabetes is a common disease caused by the interaction of genetic and environmental factors. The main clinical sign is high blood sugar. Common symptoms include polydipsia, polyuria, polyphagia, and weight loss. Diabetes can cause damage to multiple systems in the body, leading to absolute or relative insulin deficiency and reduced insulin sensitivity of target tissue cells, causing a series of metabolic disorders such as protein, fat, water, and electrolytes. Significant increase in blood sugar can cause acute complications such as diabetic ketoacidosis and hyperosmolar coma. Long-term illness can also cause vascular and neuropathy, resulting in damage to multiple organs and tissues such as the heart, brain, kidneys, eyes, nerves, and skin, affecting the patient's quality of life and even shortening life expectancy. Active prevention and treatment should be carried out.
Related Drugs
Sodium Bicarbonate Injection
Indication: 1. Treatment of metabolic acidosis. For the treatment of mild to moderate metabolic acidosis, oral administration is preferred. Severe metabolic acidosis should be treated by intravenous drip, such as severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. 2. Alkalize urine. Used for the prevention of uric acid kidney stones, reducing the nephrotoxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. 3. As an antacid, it treats symptoms caused by excessive gastric acid. 4. Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates and methanol. However, this product is contraindicated for gastric lavage when swallowed in case of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which leads to acute gastric dilatation or even gastric rupture.
Manufacturer:

Xinhe Yuansheng MEDICINE Co., Ltd.

Sodium Bicarbonate Injection
Indication: 1. Treatment of metabolic acidosis. For the treatment of mild to moderate metabolic acidosis, oral administration is preferred. Severe metabolic acidosis should be treated by intravenous drip, such as severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. 2. Alkalize urine. Used for the prevention of uric acid kidney stones, reducing the nephrotoxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. 3. As an antacid, it treats symptoms caused by excessive gastric acid. 4. Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates and methanol. However, this product is contraindicated for gastric lavage when swallowed in case of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which leads to acute gastric dilatation or even gastric rupture.
Sodium Bicarbonate Injection
Indication: 1. Treatment of metabolic acidosis. For the treatment of mild to moderate metabolic acidosis, oral administration is preferred. Severe metabolic acidosis should be treated by intravenous drip, such as severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. 2. Alkalize urine. Used for the prevention of uric acid kidney stones, reducing the nephrotoxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. 3. As an antacid, it treats symptoms caused by excessive gastric acid. 4. Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates and methanol. However, this product is contraindicated for gastric lavage when swallowed in case of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which leads to acute gastric dilatation or even gastric rupture.
Manufacturer:

Fuzhou FU Yao Pharmaceutical Co., Ltd.

Sodium Bicarbonate Injection
Indication: 1. Treatment of metabolic acidosis. For the treatment of mild to moderate metabolic acidosis, oral administration is preferred. Severe metabolic acidosis should be treated by intravenous drip, such as severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. 2. Alkalize urine. Used for the prevention of uric acid kidney stones, reducing the nephrotoxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. 3. As an antacid, it treats symptoms caused by excessive gastric acid. 4. Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates and methanol. However, this product is contraindicated for gastric lavage when swallowed in case of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which leads to acute gastric dilatation or even gastric rupture.
Manufacturer:

Harbin Pharm. Group Sanjing Pharmaceutical Co., Ltd.

Sodium Bicarbonate Injection
Indication: 1. Treatment of metabolic acidosis. For the treatment of mild to moderate metabolic acidosis, oral administration is preferred. Severe metabolic acidosis should be treated by intravenous drip, such as severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. 2. Alkalize urine. Used for the prevention of uric acid kidney stones, reducing the nephrotoxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. 3. As an antacid, it treats symptoms caused by excessive gastric acid. 4. Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates and methanol. However, this product is contraindicated for gastric lavage when swallowed in case of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which leads to acute gastric dilatation or even gastric rupture.
Sodium Bicarbonate Injection
Indication: 1. Treatment of metabolic acidosis. For the treatment of mild to moderate metabolic acidosis, oral administration is preferred. Severe metabolic acidosis should be treated by intravenous drip, such as severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. 2. Alkalize urine. Used for the prevention of uric acid kidney stones, reducing the nephrotoxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. 3. As an antacid, it treats symptoms caused by excessive gastric acid. 4. Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates and methanol. However, this product is contraindicated for gastric lavage when swallowed in case of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which leads to acute gastric dilatation or even gastric rupture.
Manufacturer:

Harbin Pharm. Group Sanjing Pharmaceutical Co., Ltd.

Sodium Bicarbonate Injection
Indication: 1. Treatment of metabolic acidosis. For the treatment of mild to moderate metabolic acidosis, oral administration is preferred. Severe metabolic acidosis should be treated by intravenous drip, such as severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. 2. Alkalize urine. Used for the prevention of uric acid kidney stones, reducing the nephrotoxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. 3. As an antacid, it treats symptoms caused by excessive gastric acid. 4. Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates and methanol. However, this product is contraindicated for gastric lavage when swallowed in case of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which leads to acute gastric dilatation or even gastric rupture.
Manufacturer:

Zhengzhou Zhuofeng Pharmaceutical Co., Ltd.

Sodium Bicarbonate Injection
Indication: 1. Treatment of metabolic acidosis. For the treatment of mild to moderate metabolic acidosis, oral administration is preferred. Severe metabolic acidosis should be treated by intravenous drip, such as severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. 2. Alkalize urine. Used for the prevention of uric acid kidney stones, reducing the nephrotoxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. 3. As an antacid, it treats symptoms caused by excessive gastric acid. 4. Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates and methanol. However, this product is contraindicated for gastric lavage when swallowed in case of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which leads to acute gastric dilatation or even gastric rupture.
Manufacturer:

Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical Co., Ltd.

Sodium Bicarbonate Injection
Indication: 1. Treatment of metabolic acidosis. For the treatment of mild to moderate metabolic acidosis, oral administration is preferred. Severe metabolic acidosis should be treated by intravenous drip, such as severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. 2. Alkalize urine. Used for the prevention of uric acid kidney stones, reducing the nephrotoxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. 3. As an antacid, it treats symptoms caused by excessive gastric acid. 4. Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates and methanol. However, this product is contraindicated for gastric lavage when swallowed in case of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which leads to acute gastric dilatation or even gastric rupture.
Manufacturer:

Tonghua Huaxia Pharmaceutical Co., Ltd.

Sodium Bicarbonate Injection
Indication: 1. Treatment of metabolic acidosis. For the treatment of mild to moderate metabolic acidosis, oral administration is preferred. Severe metabolic acidosis should be treated by intravenous drip, such as severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. 2. Alkalize urine. Used for the prevention of uric acid kidney stones, reducing the nephrotoxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. 3. As an antacid, it treats symptoms caused by excessive gastric acid. 4. Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates and methanol. However, this product is contraindicated for gastric lavage when swallowed in case of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which leads to acute gastric dilatation or even gastric rupture.
Manufacturer:

Shaanxi Dunsi Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.